INARI MEDICAL INC (NARI) Earnings History & Surprises
NASDAQ:NARI • US45332Y1091
79.97 USD
+0.04 (+0.05%)
At close: Feb 18, 2025
79.98 USD
+0.01 (+0.01%)
After Hours: 2/18/2025, 8:00:58 PM
Past quarterly earnings results for INARI MEDICAL INC (NARI), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateMar 4, 2025
PeriodQ4 / 2024
EPS Estimate$0.01
Revenue Estimate163.82M
Last Reported
Release DateOct 28, 2024
PeriodQ3 / 2024
EPS Reported-$0.09
EPS Surprise 31.16%
Revenue Surprise -0.19%
Beat Rate
63%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2024 | -0.09 | -0.13 | 31.16% | -280.00% | 153.39M | 153.68M | -0.19% | 21.39% |
| Q2 2024 | -0.38 | -0.15 | -154.00% | -1,050.00% | 145.82M | 146.62M | -0.55% | 22.53% |
| Q1 2024 | -0.22 | -0.20 | -7.77% | -450.00% | 143.194M | 141.14M | 1.46% | 23.27% |
| Q4 2023 | -0.08 | 0.01 | -1,407.19% | 27.27% | 132.094M | 134.42M | -1.73% | 22.54% |
| Q3 2023 | 0.05 | 0.00 | 1,004.05% | 126.32% | 126.366M | 124.36M | 1.61% | 31.36% |
| Q2 2023 | 0.04 | -0.13 | 131.02% | 121.05% | 119.005M | 118.96M | 0.04% | 28.38% |
| Q1 2023 | -0.04 | -0.23 | 82.67% | 33.33% | 116.167M | 112.5M | 3.26% | 33.83% |
| Q4 2022 | -0.11 | -0.17 | 37.03% | -650.00% | 107.8M | 106.94M | 0.80% | 29.57% |
| Q3 2022 | -0.19 | -0.26 | 26.59% | -216.67% | 96.2M | 92.21M | 4.33% | 31.96% |
| Q2 2022 | -0.19 | -0.23 | 19.01% | -371.43% | 92.7M | 89.558M | 3.51% | 45.98% |
| Q1 2022 | -0.06 | -0.09 | 35.83% | -146.15% | 86.8M | 85.281M | 1.78% | 51.22% |
| Q4 2021 | 0.02 | 0.03 | -24.59% | -84.62% | 83.2M | 79.721M | 4.36% | 71.19% |
| Q3 2021 | -0.06 | -0.11 | 46.52% | -150.00% | 72.9M | 64.291M | 13.39% | 88.37% |
| Q2 2021 | 0.07 | 0.08 | -15.97% | 143.75% | 63.5M | 60.839M | 4.37% | 150.00% |
| Q1 2021 | 0.13 | 0.05 | 146.66% | - | 57.4M | 56.238M | 2.07% | 112.59% |
| Q4 2020 | 0.13 | 0.01 | 856.12% | - | 48.6M | 41.905M | 15.98% | - |
| Q3 2020 | 0.12 | -0.04 | 409.60% | - | 38.7M | 27.065M | 42.99% | - |
| Q2 2020 | -0.16 | -0.18 | 11.21% | - | 25.4M | 13.413M | 89.37% | - |
| Q1 2020 | 0.13 | - | - | 27M | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
-384.45%
Max EPS beat (4)
31.16%
Min EPS beat (4)
-1,407.19%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
-0.25%
Max Revenue beat (4)
1.46%
Min Revenue beat (4)
-1.73%
Analysis
In the last 4 quarters, NARI has beaten EPS estimates in 1 out of 4 releases
NARI has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, NARI reported -384.5% below the EPS estimates on average.
In the last 4 quarters, NARI reported -0.3% below the revenue estimates on average.
INARI MEDICAL INC / NARI Earnings FAQ
What is the most recent earnings date for NARI stock?
INARI MEDICAL INC (NARI) last reported earnings on 10/28/2024.
Did NARI stock beat earnings estimates in the most recent quarter?
INARI MEDICAL INC (NARI) beat EPS estimates and missed revenue estimates in the most recent quarter.
What percentage of the time does NARI stock beat earnings estimates?
In the last 4 quarters, INARI MEDICAL INC (NARI) has beaten EPS estimates in 1 out of 4 releases.